Pharmacotherapy for Patients With Borderline Personality Disorder

To the Editor.—  The Archives is to be commended for publishing in the same issue our article¹ and that of Soloff et al² because it is exceedingly rare that two independent groups of investigators find essentially the same results while using somewhat different drugs, diagnostic methods, and patients. The differences between the studies attest to the robustness of the results. We were further flattered by the invitation of John Gunderson,³ an eminent contributor to the dynamics, diagnosis, and psychotherapy for borderline disorders, to discuss the implications of the two reports.Some of Gunderson's commentary, however, seems to imply that the results have more limited value than might first appear to be the case. Gunderson believes that the real message of the studies is that pharmacotherapy has a limited role as a useful adjunct for some but not all patients. We have no argument with the phrase "some